Stock Price
20.38
Daily Change
-0.10 -0.49%
Monthly
20.59%
Yearly
72.71%
Q2 Forecast
19.77



Peers Price Chg Day Year Date
Agrana Beteiligungs 11.90 -0.10 -0.83% 0.85% May/15
Austevoll Seafood 93.30 2.60 2.87% -7.62% May/15
British American Tobacco 4,864.00 -98.00 -1.98% 50.87% May/16
Beiersdorf 70.06 -0.52 -0.74% -42.05% May/16
Danone 61.24 -0.62 -1.00% -17.89% May/16
Givaudan 2,700.00 17.00 0.63% -33.99% May/15
Glanbia 20.38 -0.10 -0.49% 72.71% May/15
Henkel 64.28 0.56 0.88% -8.59% May/16
International Flavors Fragrances 73.10 -2.99 -3.93% -5.94% May/15
Imperial Brands 2,817.00 -49.00 -1.71% 4.18% May/15

Indexes Price Day Year Date
ISEQ 12398 -187.42 -1.49% 11.94% May/15
EU600 607 -9.13 -1.48% 10.50% May/15

Glanbia traded at 20.38 this Friday May 15th, decreasing 0.10 or 0.49 percent since the previous trading session. Looking back, over the last four weeks, Glanbia lost 20.59 percent. Over the last 12 months, its price rose by 72.71 percent. Looking ahead, we forecast Glanbia to be priced at 19.77 by the end of this quarter and at 18.03 in one year, according to Trading Economics global macro models projections and analysts expectations.

Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The Company's Glanbia Nutritionals segment provides nutritional solutions. It manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.